.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Teva
Fish and Richardson
Healthtrust
Merck
AstraZeneca
Medtronic
Novartis
Johnson and Johnson
Covington

Generated: September 26, 2017

DrugPatentWatch Database Preview

Vernalis R And D Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for VERNALIS R AND D LTD, and when can generic versions of VERNALIS R AND D LTD drugs launch?

VERNALIS R AND D LTD has two approved drugs.

There are eight US patents protecting VERNALIS R AND D LTD drugs.

There are fifty-six patent family members on VERNALIS R AND D LTD drugs in fourteen countries.

Summary for Applicant: Vernalis R And D Ltd

Patents:8
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Vernalis R And D Ltd
TUZISTRA XR
chlorpheniramine polistirex; codeine polistirex
SUSPENSION, EXTENDED RELEASE;ORAL207768-001Apr 30, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Vernalis R And D Ltd
TUZISTRA XR
chlorpheniramine polistirex; codeine polistirex
SUSPENSION, EXTENDED RELEASE;ORAL207768-001Apr 30, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Vernalis R And D Ltd
MOXATAG
amoxicillin
TABLET, EXTENDED RELEASE;ORAL050813-001Jan 23, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Vernalis R And D Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,303,988Antifungal once-a-day product, use and formulation thereof► Subscribe
6,541,014 Antiviral product, use and formulation thereof► Subscribe
7,025,989Multiple-delayed released antibiotic product, use and formulation thereof► Subscribe
8,747,902Modified release formulations containing drug-ion exchange resin complexes► Subscribe
7,074,417Multiple-delayed release anti-viral product, use and formulation thereof► Subscribe
8,597,684Modified release formulations containing drug-ion exchange resin complexes► Subscribe
6,984,401Antiviral product, use and formulation thereof► Subscribe
9,675,704Modified release formulations containing drug-ion exchange resin complexes► Subscribe
8,337,890Modified release formulations containing drug-ion exchange resin complexes► Subscribe
9,675,703Modified release formulations containing drug - ion exchange resin complexes► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Vernalis R And D Ltd Drugs

Country Document Number Estimated Expiration
Australia2003262626► Subscribe
Japan5479086► Subscribe
Canada2645855► Subscribe
European Patent Office1542656► Subscribe
World Intellectual Property Organization (WIPO)2004012509► Subscribe
Canada2470016► Subscribe
Canada2635606► Subscribe
Australia2003261359► Subscribe
Australia2007227569► Subscribe
Australia2002359768► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
McKinsey
Express Scripts
Dow
Teva
Covington
Merck
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot